Lurie David M, Milner Rowan J, Suter Steven E, Vernau William
Department of Small Animal Clinical Sciences, University of Florida, Gainesville, FL 32610, USA.
Vet Immunol Immunopathol. 2008 Sep 15;125(1-2):102-10. doi: 10.1016/j.vetimm.2008.05.009. Epub 2008 May 21.
The boxer breed is at high risk for developing lymphoma and, in contrast to the general canine population, is predisposed to the T-cell variant of the disease. The purpose of this study was to more accurately classify lymphoma in this breed. Clinical, cytomorphologic and immunophenotypic data were examined in 43 boxers with lymphoma. Twenty-five cases were collected prospectively and a further 18 cases were obtained retrospectively. Lymphomas were classified as multicentric (n=29), mediastinal (n=6) and intestinal (n=8). Of the 40 immunophenotyped samples, 34 (85%) were T-cell, 5 (12.5%) were B-cell and 1 was a non-B-cell non-T-cell lymphoma. Immunophenotypic subtyping was done on prospectively collected T-cell lymphoma samples (n=22) to differentiate CD4 (helper) from CD8 (cytotoxic) T-cell origin as well as to determine the T-cell receptor (TCR) expression (TCRalphabeta vs. TCRdeltagamma). Phenotypic expression was CD4+ (n=12), double negative (DN) (n=6), double positive (DP) (n=1) and CD8+ (n=1), respectively, while two samples had no interpretable result. 20/22 samples were TCRalphabeta+ with only 1 sample being TCRdeltagamma+ and 1 with no interpretable result. Cytomorphologic analysis was done on the same 22 samples using the World Health Organization (WHO) classification scheme. According to this scheme, 17/22 samples were classified as lymphoblastic, 2/22 as large cell peripheral T-cell lymphoma-not otherwise specified (PTCL-NOS), 2/22 as large granular lymphoma (LGL) high-grade and 1/22 as small lymphocytic. The results of this study indicate that lymphoma in the boxer breed is a disease comprised predominantly of TCRalphabeta+, CD4+ (helper) T-cells with lymphoblastic (high-grade) morphology.
拳师犬种患淋巴瘤的风险很高,与一般犬类群体不同,该犬种易患T细胞型淋巴瘤。本研究的目的是更准确地对该犬种的淋巴瘤进行分类。对43只患有淋巴瘤的拳师犬的临床、细胞形态学和免疫表型数据进行了检查。前瞻性收集了25例病例,另外回顾性获得了18例病例。淋巴瘤分为多中心型(n = 29)、纵隔型(n = 6)和肠道型(n = 8)。在40份进行免疫表型分析的样本中,34份(85%)为T细胞型,5份(12.5%)为B细胞型,1份为非B细胞非T细胞淋巴瘤。对前瞻性收集的T细胞淋巴瘤样本(n = 22)进行免疫表型亚型分析,以区分CD4(辅助性)和CD8(细胞毒性)T细胞来源,并确定T细胞受体(TCR)表达(TCRαβ与TCRδγ)。表型表达分别为CD4 +(n = 12)、双阴性(DN)(n = 6)、双阳性(DP)(n = 1)和CD8 +(n = 1),而两份样本没有可解释的结果。22份样本中有20份为TCRαβ +,只有1份为TCRδγ +,1份没有可解释的结果。使用世界卫生组织(WHO)分类方案对相同的22份样本进行细胞形态学分析。根据该方案,22份样本中有17份被分类为淋巴母细胞性,2份为未另行指定的大细胞外周T细胞淋巴瘤(PTCL-NOS),2份为高级别大颗粒淋巴瘤(LGL),1份为小淋巴细胞性。本研究结果表明,拳师犬种的淋巴瘤主要是一种由TCRαβ +、CD4 +(辅助性)T细胞组成且具有淋巴母细胞性(高级别)形态的疾病。